CSIRO PUBLISHING | Australian Health Review

AH090171The economic crisis, the Pharmaceutical Benefits Scheme, and the dilemmas of medicines policy

Hans Löfgren

pp. 171-175

AH090171 Abstract | AH090171PDF (146 KB)

AH090176PBS reform — a missed opportunity?

Rebecca de Boer

pp. 176-185

AH090176 Abstract | AH090176PDF (201 KB)

AH090186The PBS in a globalised world: free trade and reference pricing

Andrew Searles

pp. 186-191

AH090186 Abstract | AH090186PDF (153 KB)

AH090192Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme

Jane Robertson, Emily J Walkom and David A Henry

pp. 192-199

AH090192 Abstract | AH090192PDF (200 KB)

AH090200High prices for generics in Australia — more competition might help

Liliana Bulfone

pp. 200-214

AH090200 Abstract | AH090200PDF (563 KB)

AH090215The impact of copayments and safety nets on PBS expenditure

Kim Sweeny

pp. 215-230

AH090215 Abstract | AH090215PDF (673 KB)

AH090231Australia's pharmaceutical cost sharing policy: reducing waste or affordability?

Evan Doran and Jane Robertson

pp. 231-240

AH090231 Abstract | AH090231PDF (224 KB)

AH090241PBS copayments and safety nets - A commentary on Sweeny and Doran and Robertson

Ruth Lopert

pp. 241-244

AH090241 Abstract | AH090241PDF (97 KB)

AH090245 Biopharmaceutical innovation and industrial developments in South Korea, Singapore and Taiwan

Chee-Ruey Hsieh and Hans Lofgren

pp. 245-257

AH090245 Abstract | AH090245PDF (265 KB)

AH090258Policy challenges of nanomedicine for Australia's PBS

Thomas A Faunce

pp. 258-267

AH090258 Abstract | AH090258PDF (217 KB)

AH090268Doctor and pharmacist — back to the apothecary!

Siaw-Teng Liaw and Gregory Peterson

pp. 268-278

AH090268 Abstract | AH090268PDF (267 KB)

AH090279A review of proposals to reform the regulation of complementary medicines

Ken J Harvey

pp. 279-287

AH090279 Abstract | AH090279PDF (181 KB)

AH090288Complementary medicines regulatory reform

Michael D Bollen and Susan D Whicker

pp. 288-294

AH090288 Abstract | AH090288PDF (147 KB)

AH090295Medicines policy and drug company investments: the Irish experience

Hans Lofgren

pp. 295-298

AH090295 Abstract | AH090295PDF (116 KB)

AH090299 Interpreting the global bio-economy

Mats Benner

pp. 299-300

AH090299 Abstract | AH090299PDF (82 KB)

AH090301Editorial: Models of Care

Deborah Yarmo-Roberts

pp. 301-302

AH090301 Abstract | AH090301PDF (83 KB)

AH090303Becoming Australian? Two different approaches to health care reform in the United States

Jessica K Roydhouse

pp. 303-310

AH090303 Abstract | AH090303PDF (212 KB)

AH090311GP access to MRI: the Australian reality

Owen M Bradfield

pp. 311-314

AH090311 Abstract | AH090311PDF (99 KB)

AH090315Working together: collaboration between midwives and doctors in public hospitals

Kerreen M Reiger and Karen L Lane

pp. 315-324

AH090315 Abstract | AH090315PDF (200 KB)

AH090325 Cholesterol-lowering therapy and the Australian Pharmaceutical Benefits Scheme: a population study

Robert J Adams, Sarah Appleton, David H Wilson, Anne W Taylor, Catherine Chittleborough, Tiffany Gill and Richard E Ruffin

pp. 325-333

AH090325 Abstract | AH090325PDF (325 KB)

AH090334The AusPSIs: the Australian version of the Agency of Healthcare Research and Quality patient safety indicators

Steven McConchie, Jennie Shepheard, Simon Waters, Alison J McMillan and Vijaya Sundararajan

pp. 334-350

AH090334 Abstract | AH090334PDF (355 KB)